Valuation: Balaxi Pharmaceuticals Limited

Market Cap 1.23B 12.74M 11.38M 10.58M 9.63M 18.17M 18.25M 127M 49.91M 629M 47.83M 46.79M 2.02B P/E 2025
14.1x
P/E 2026 61.1x
Enterprise Value 1.64B 16.99M 15.17M 14.11M 12.84M 24.24M 24.34M 170M 66.55M 838M 63.78M 62.39M 2.69B EV / Sales 2025
1.16x
EV / Sales 2026 0.47x
Free-Float
90.84%
Yield 2025 *
-
Yield 2026 -
1 day+1.09%
1 week-0.04%
Current month-1.98%
1 month-3.92%
3 months-7.61%
6 months-6.14%
Current year-16.90%
1 week 21.05
Extreme 21.05
23.49
1 month 21
Extreme 21
24.8
Current year 15.2
Extreme 15.2
29.9
1 year 15.2
Extreme 15.2
44.36
3 years 15.2
Extreme 15.2
151.45
5 years 15.2
Extreme 15.2
151.45
10 years 2.58
Extreme 2.58
216.04
Manager TitleAgeSince
Chief Executive Officer 56 2017-05-03
Director of Finance/CFO - 2021-05-19
Compliance Officer - 2026-03-24
Director TitleAgeSince
Chairman 56 2017-05-03
Director/Board Member 54 -
Director/Board Member 44 2017-05-03
Change 5-day change 1-year change 3-year change Capi.($)
+1.09%-0.04%-48.63%-74.68% 12.74M
+0.83%+3.19%+41.49%+103.56% 1,051B
+1.93%+2.11%+37.08%+65.09% 630B
+1.49%+5.19%+19.94%+85.69% 489B
+2.26%+0.90%+69.32%+40.53% 359B
+1.45%+3.50%+23.29%+41.62% 344B
+1.17%+2.37%+13.47%+33.64% 272B
+0.89%+1.08%-6.13%+9.29% 246B
+1.82%+2.94%+42.99%+52.95% 224B
+2.77%+4.44%+29.01%+98.99% 187B
Average +1.57%+2.27%+22.18%+45.67% 380.37B
Weighted average by Cap. +1.47%+2.44%+33.36%+69.01%

Financials

2025 2026
Net sales 2.93B 30.23M 27M 25.11M 22.84M 43.13M 43.32M 302M 118M 1.49B 114M 111M 4.79B 2.7B 27.92M 24.93M 23.19M 21.1M 39.83M 40M 279M 109M 1.38B 105M 103M 4.42B
Net income 251M 2.59M 2.31M 2.15M 1.96M 3.7M 3.71M 25.9M 10.15M 128M 9.73M 9.51M 410M 14.17M 146K 131K 122K 111K 209K 210K 1.46M 574K 7.22M 550K 538K 23.18M
Net Debt 127M 1.31M 1.17M 1.09M 993K 1.88M 1.88M 13.14M 5.15M 64.86M 4.94M 4.83M 208M 411M 4.25M 3.79M 3.53M 3.21M 6.06M 6.09M 42.47M 16.64M 210M 15.95M 15.6M 673M
Projected Income Statement - Annual - Balaxi Pharmaceuticals Limited
Logo Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.
Employees
500
Date Price Change Volume
26-10-09 ₹22.33 +1.09% 13,772
26-10-08 ₹22.09 -1.30% 61,447
26-10-07 ₹22.38 -1.28% 15,155
26-10-06 ₹22.67 -0.44% 8,384
26-10-05 ₹22.77 +1.92% 22,927
  1. Stock Market
  2. Stocks
  3. BALAXI Stock